Literature DB >> 21285159

Work disability in patients with ankylosing spondylitis in Norway.

Gunnstein Bakland1, Jan T Gran, Andrea Becker-Merok, Bjørn Y Nordvåg, Johannes C Nossent.   

Abstract

OBJECTIVE: To report the prevalence of work disability (WD) in a cross-sectional study of a large population of patients with ankylosing spondylitis (AS) and the associated demographic and clinical characteristics, including extraspinal features, that contribute to WD.
METHODS: Patients with AS registered in a hospital database were invited to participate. A total of 360 patients took part. The survey period was 1998 to 2002. During an extended outpatient visit, data were collected according to a predefined data form. Demographic data were collected and a physical examination performed.
RESULTS: After 22.6 years of disease duration, the cumulative prevalence of WD reached 43.6%, and an additional 8.9% of patients were nonparticipants in the labor force. Significant odds ratios indicating an independent association with WD were found for history of polyarthritis (9.6), coronary heart disease (CHD; 7.8), female sex (3.4), having children with spondyloarthritis (2.9), changing profession (2.8), lower level of education (1.4), mean score of the Bath AS Functional Index (1.2), increasing age (1.05), and increasing finger-to-floor distance (1.02).
CONCLUSION: The longterm prevalence of WD among Norwegian patients with AS is considerably higher than in reports from other countries. Earlier polyarthritis and CHD were the strongest independent risk factors for WD.

Entities:  

Mesh:

Year:  2011        PMID: 21285159     DOI: 10.3899/jrheum.100686

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

1.  Anthrax toxin receptor 2 gene (ANTXR2) rs4333130 is associated with ankylosing spondylitis.

Authors:  Yanjuan Ou
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  The use of anti-TNF therapy for ankylosing spondylitis in everyday rheumatology practice and the relationship to disease activity, work disability and diagnostic delay.

Authors:  C Sullivan; K Quinn; S Harney; J G Ryan
Journal:  Ir J Med Sci       Date:  2013-12-21       Impact factor: 1.568

3.  TNF-α and IL10 polymorphisms interaction increases the risk of ankylosing spondylitis in Chinese Han population.

Authors:  Nai-Guo Wang; Da-Chuan Wang; Bing-Yi Tan; Feng Wang; Ze-Nong Yuan
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

4.  The Cost of Ankylosing Spondylitis in the UK Using Linked Routine and Patient-Reported Survey Data.

Authors:  Roxanne Cooksey; Muhammad J Husain; Sinead Brophy; Helen Davies; Muhammad A Rahman; Mark D Atkinson; Ceri J Phillips; Stefan Siebert
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

5.  Association Between Protein Tyrosine Phosphatase Non-Receptor Type 22 (PTPN22) Polymorphisms and Risk of Ankylosing Spondylitis: A Meta-analysis.

Authors:  Weiming Wang; Xiantao Meng; Yupeng Liu; Xiaojun Ma; Qian Zhang; Chunhui Li; Chenye Li; Liubao Ren
Journal:  Med Sci Monit       Date:  2017-05-30

6.  Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study.

Authors:  Casper Webers; Sofia Ramiro; Robert Landewé; Désirée van der Heijde; Filip van den Bosch; Maxime Dougados; Astrid van Tubergen; Annelies Boonen
Journal:  RMD Open       Date:  2018-11-27

7.  IL-1A gene variation in relation to cytokine levels and clinical characteristics in ankylosing spondylitis.

Authors:  Johannes C Nossent; Sylvia Sagen-Johnsen; Gunnstein Bakland
Journal:  Eur J Rheumatol       Date:  2018-12-18

8.  The Association Between TNF Inhibitor Therapy Availability and Hospital Admission Rates for Patients with Ankylosing Spondylitis. A Longitudinal Population-Based Study.

Authors:  Johannes Nossent; Charles Inderjeeth; Helen Keen; David Preen; Ian Li; Erin Kelty
Journal:  Rheumatol Ther       Date:  2021-11-11

9.  Adverse events of anti-tumor necrosis factor α therapy in ankylosing spondylitis.

Authors:  Qiang Tong; Qing Cai; Tristan de Mooij; Xia Xu; Shengming Dai; Wenchun Qu; Dongbao Zhao
Journal:  PLoS One       Date:  2015-03-12       Impact factor: 3.240

10.  Sick leave in early axial spondyloarthritis: the role of clinical and socioeconomic factors. Five-year data from the DESIR cohort.

Authors:  Elena Nikiphorou; Pedro D Carvalho; Annelies Boonen; Bruno Fautrel; Pascal Richette; Pedro M Machado; Desirée van der Heijde; Robert Landewé; Sofia Ramiro
Journal:  RMD Open       Date:  2021-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.